Insights Across the
Access Ecosystem

Free-goods and foundation funding alone can’t sustain today’s Patient Assistance Programs. The HealthPACER® PAP Calculator introduces real-time eligibility logic, audit-ready workflows, and diversified funding options to help manufacturers design compliant, efficient, and resilient programs that stand up to policy shifts and scale demands.

One immunology team transformed its launch strategy in just 5 days with MAVA®. See how real payer feedback and scenario modeling delivered faster, better outcomes.

Discover how HealthPACER® FRM dashboards give field teams real-time visibility into cases, improve provider experience, and accelerate patient access.

Coverage isn’t only about rebates. P&T committees weigh evidence relevance, comparator choice, contracting tactics, and the strength of your value story. Learn how leading teams are using payer panels to pressure-test strategy before formulary placement decisions.

Payers aren’t asking for more data—they’re demanding the right data. In 2025, endpoints that once secured access may no longer resonate. Manufacturers must validate their value story against evolving payer expectations or risk raising red flags that derail coverage and contracting decisions.

On World Patient Safety Day, see how eMAX Health Patient Services embeds safety into access workflows for newborns, children, and their families.

See how HealthPACER® accelerates benefit verification, ePA, and appeals to cut delays, ease provider burden, and get patients on therapy faster.

Static annual market access research can’t keep pace with today’s rapid policy, pricing, and payer shifts. Learn why high-performing pharmaceutical teams are adopting iterative, agile insight loops, and how this new model is transforming launch and portfolio strategy.

CMS’s new Healthcare Advisory Committee targets efficiency and outcomes. Here’s how patient services can adapt now to reduce burden and speed access.

HHS and CMS have formed a new Healthcare Advisory Committee to reshape how federal payers finance and deliver care. Learn how this could impact pharma market access—and why agile insight platforms like MAVA™ are essential to adapt.

Hybrid and insourced patient support models give pharmaceutical manufacturers the flexibility and control missing in fully outsourced hubs. With HealthPACER® and expert operational support, eMAX Health Patient Services helps brands streamline access, strengthen compliance, and design scalable patient services that adapt to market demands.

Many pharma manufacturers are stuck between outdated patient support models and rising access challenges. In this post, eMAX Health Patient Services explores how flexible strategies like hybrid support models, scalable tech platforms, and alternative funding solutions, can help manufacturers modernize their Patient Assistance Programs and improve outcomes across the product lifecycle.

As policy shifts, pricing pressures, and compliance demands reshape the healthcare landscape, traditional Patient Support Programs (PSPs) are struggling to keep up. In this post, eMAX Health Patient Services explores why manufacturers must reimagine their PSP strategies to ensure sustainability, regulatory resilience, and brand alignment in today’s high-stakes environment.

The launch of FluMist Home signals a major shift in healthcare delivery, where patients can complete the full treatment journey without entering a clinic. In this post, Mary Lynn Kelley, President of eMAX Health Patient Services, explores what this means for specialty therapies and patient access programs. From benefit verification and affordability support to compliance and safety monitoring, the future of patient services will require flexible, tech-enabled models that can

The Most-Favored-Nation Executive Order deadline has passed. Learn how pharma teams can use MAVA®, Elasticity™, Contracting ROI, and SCORE™ to adapt pricing strategy, validate assumptions, and stay ahead of regulatory enforcement.

Discover how Elasticity™, built into the MAVA® platform, helps Commercial and Medical teams model real-world pricing and value scenarios side by side. Align internal stakeholders, quantify value, and validate pricing strategy before launch.

Discover how MAVA™ by eMAX Health helps pharma teams model rebate ROI, forecast market access impact, and make smarter contracting decisions using real payer claims data. Join our expert panel of 5,000+ healthcare leaders shaping pharmaceutical access strategy.

Facing competitive pressure and access challenges, an immunology brand used MAVA® and Elasticity™ to rethink its launch strategy in 5 days, reshaping contracts, evidence needs, and pricing to avoid costly missteps.

How are high-performing pharma teams staying ahead in today’s fast-moving market access landscape? Julian Casciano, CEO of eMAX Health, shares insight on building dynamic feedback loops and how MAVA™ supports real-time strategy.

Today’s payers expect real-world relevance, not just more data. Learn why leading access teams are pressure-testing HEOR assumptions early using real-time platforms, and how pre-submission validation helps ensure your evidence package resonates and withstands scrutiny.